Victor Jimenez Zepeda
MD
Associate Professor
Arnie Charbonneau Cancer Research institute

Victor Jimenez-Zepeda, MD, is an Associate Professor of Medicine at the University of Calgary. Member of the Arnie Charbonneau Cancer Research Institute and Co-director of the Amyloidosis Program of Calgary. Dr Jimenez Zepeda is a medical school graduate from the University of Guadalajara in Mexico. He trained in internal medicine and hematology at the National Institute of Medical Sciences and Nutrition in Mexico City. He has obtained specialized training in Lymphoma and myeloma under the mentorships of Drs. Joan Blade and Armando Lopez-Guillermo in Barcelona, and from 2007 to 2009, obtained bench training in genetics and myeloma under the supervision of Drs Rafael Fonseca, Keith Stewart and Leif Bergsagel at the Mayo Clinic in Arizona. Dr Jimenez-Zepeda completed a Clinical and Research Fellowship in Myeloma and Amyloidosis at the Princess Margaret Cancer Center and in 2013 he moved to Calgary and has been there since. More recently, he spent some time as a visitor Professor at the Amyloid Center in Pavia (Italy) and the National Amyloid Center in London (UK) (2019). Dr Zepeda is member of the American Society of Hematology, International Society of Amyloidosis, International Kidney and Monoclonal gammopathies group, Myeloma Canada Research Network, International Myeloma Society and is one of the founders of the Canadian Society of Amyloidosis (CAS). Dr Zepeda has ~300 journal publications and abstracts to his credit with more than 110 peer review articles in pubmed. He has been awarded with the ASH Abstract Achievement Award and the Multiple Myeloma Research Foundation Award.

Sessions

Register
General Session

Updates in Precursor Disorders

Saturday, February 08, 2025
11:30 AM - 11:50 AM
General Session

From Data to Impact: Improving Clinical Decisions (Patient Case Presentation & Discussion)

Saturday, February 08, 2025
12:30 PM - 12:50 PM
General Session

Questions & Answers

Saturday, February 08, 2025
12:50 PM - 1:10 PM